Heterogeneity and Precision Oncology in Circulating Tumor Cells
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: closed (15 April 2024) | Viewed by 3535
Special Issue Editors
2. Institute for Glycomics, Griffith University, Gold Coast, QLD 4222, Australia
Interests: molecular pathology; cancer; anticancer drugs; cancer marker; drug delivery; cancer pathogenesis
Interests: diagnosis of cancer; molecular pathology of cancer; treatment of cancers; endocrine cancer; gastrointestinal cancer; head and neck tumors
Special Issue Information
Dear Colleagues,
Circulating tumor cells (CTCs) are a rare subpopulation of cells found in the blood of patients with cancer. CTCs present in the blood have the potential to be used as a liquid biopsy for the early diagnosis, prognosis, and therapy response related to various cancers (e.g., breast, colon, gastric, lung, prostate, and hematological malignancies), in comparison to more conventional forms of tumor tissue biopsies. It is a treatment that is less invasive, more precise, and can be processed rapidly by collecting peripheral blood from the patients. As they share common genetic and/or epigenetic alterations similar to primary/secondary tumors, the real-time sampling of CTCs could provide us with a critical insight into the tumor’s molecular structure (i.e., the heterogeneity of cancer) without resorting to the use of an invasive tissue biopsy, which can be useful in therapy selection and response monitoring in cancer patients. The heterogeneous nature of cancer is associated with inefficient clinical outcomes; therefore, the characterization of CTCs followed by their identification in clinical settings has the potential for use as an effective prognostic and therapeutic biomarker for selecting personalized precision-treatment options, resulting in the improved management of patients with cancer.
Dr. Farhadul Islam
Prof. Dr. Alfred King-Yin Lam
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer progression
- cancer pathogenesis
- prognostic marker
- cancer heterogeneity
- precision oncology
- circulating tumor cells
- cancer screening
- therapy response
- survival
- CTC isolation
- CTC enrichment
